Phase 2 Ivonescimab Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

IvonescimabClear Cell Renal Carcinoma

M.D. Anderson Cancer Center40 enrolled1 locationNCT06940518

Recruiting

Phase 1Phase 2

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Esophageal Squamous Cell CarcinomaNeoadjuvantIvonescimab

Tang-Du Hospital45 enrolled1 locationNCT07385001